Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

MeridianLink NYSE MLNK Reports Q4 2023 Earnings Below Analyst Predictions Optimistic for 2024

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
TMUS stock news
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

MeridianLink (NYSE: MLNK) revealed a loss of $(0.290) per share in Q4 2023, significantly below the analyst prediction of $(0.070) by a staggering 314.29%. This represents a notable decline from earnings of $0.010 per share during the same period the previous year.

The company’s quarterly sales totaled $74.579 million, slightly surpassing the analyst forecast of $74.575 million by a mere 0.01% and demonstrating a 5.71% increase from the prior year.

Looking ahead to the quarter ending in March, MeridianLink is expecting revenue to fall within the range of $75 million. Despite economic challenges, the company has displayed resilience and is optimistic about its prospects for 2024. Forecasts for Q1 revenue range from $75.0 million to $78.0 million.

As of March 5, 2024, MeridianLink remains confident in its ability to navigate the current market conditions and achieve its projected revenue goals.

MLNK Stock Price Update: March 5, 2024 – Analysis and Outlook

On March 5, 2024, MLNK stock experienced a slight decrease in price during regular trading hours, closing at $18.89, which was a $0.03 drop from the previous market close. In after-hours trading, the stock saw a slight uptick, rising by $0.11. Investors and analysts will be keeping a close eye on how MLNK performs in the coming days to see if it can maintain its current momentum. The after-hours trading activity suggests that there may be some positive sentiment surrounding the stock. It will be important to monitor how it performs during regular trading hours to get a clearer picture of its overall trajectory. Investors should continue to monitor the stock closely to make informed decisions about their investments.

MLNK Stock Performance Analysis: Positive Growth in Net Income and EPS

On March 5, 2024, MLNK stock had some mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $288.05 million, which showed a 7.61% increase compared to the previous year. However, the total revenue for the third quarter was $76.49 million, indicating a flat performance compared to the previous quarter. In terms of net income, MLNK reported a net income of $1.29 million for the past year, which represented a significant increase of 112.95% compared to the previous year. However, the net income for the third quarter was -$2.07 million, showing a decrease compared to the previous quarter. Despite this decrease, the net income for the third quarter still showed a positive trend with a 60.44% increase compared to the previous quarter. Earnings per share (EPS) also showed a positive performance for MLNK stock. The EPS for the past year was reported at $0.02, representing a 104.05% increase compared to the previous year. Similarly, the EPS for the third quarter was -$0.03, showing a positive trend with a 60.53% increase compared to the previous quarter. Overall, despite some fluctuations in the financial performance of MLNK stock on March 5, 2024, the company showed positive growth in terms of net income and earnings per share compared to the previous year. Investors may want to keep an eye on future financial reports to assess the company’s performance and make informed investment decisions.

Tags: MLNK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Assets (2)

Cadre Holdings Reports Impressive Q4 Earnings

Technology Quantum computing Market Capitalization

Aeva Technologies Reports Strong FourthQuarter 2023 Financial Results

Technology Data analytics Stock Exchange

MeridianLink NYSE MLNK Q4 Earnings Report Analysis Missed Estimates but Revenue Growth Seen

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com